Leerink Partners Upgrades ARS Pharmaceuticals Inc (SPRY) to Outperform

Go back to Leerink Partners Upgrades ARS Pharmaceuticals Inc (SPRY) to Outperform
(NASDAQ: SPRY) Delayed: 7.88 -0.22 (2.72%)
Previous Close $8.10    52 Week High
Open $8.10    52 Week Low
Day High $8.26    P/E N/A 
Day Low $7.82    EPS
Volume 1,155,798